Article
Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
European journal of cancer (Oxford, England : 1990) - 1 Mar 2018
Star Phoebe, Goodwin Annabel, Kapoor Rony, Conway R Max, Long Georgina V, Scolyer Richard A, Guitera Pascale
Abstract excerpt
The germline BAP1 (BRCA1-associated protein-1) mutation and associated cancer pre-disposition syndrome was first described in 2011. Since then, physicians have considered this diagnosis for patients with a characteristic personal or family history of BAP1-associated tumours (mainly uveal and cutaneous melanoma, pleural/peritoneal mesothelioma, renal cell carcinoma and BAP1-deficient melanocytic lesions). However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
